1368. Assessment of the In Vivo Efficacy of Human-Simulated Epithelial Lining Fluid (ELF) Exposure of Meropenem/Nacubactam (MEM/NAC) Combination Against β-Lactamase-Producing Enterobacteriaceae in Neutropenic Lung Infection Model

BACKGROUND: NAC is a novel dual action β-lactamase inhibitor with in vitro activity against class A, class C, and some class D β-lactamases and antibacterial activity against Enterobactaeriaceae. NAC is being developed as a combination therapy with MEM for the treatment of serious Gram-negative bact...

Descripción completa

Detalles Bibliográficos
Autores principales: Asempa, Tomefa E, Motos, Ana, Abdelraouf, Kamilia, Bissantz, Caterina, Zampaloni, Claudia, Nicolau, David P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253160/
http://dx.doi.org/10.1093/ofid/ofy210.1199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253160/
http://dx.doi.org/10.1093/ofid/ofy210.1199

Ejemplares similares